Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Category: CD derivatives

January 25, 2021 CD as API / CD derivatives / Pharma applications

Cyclodextrin-mediated quorum quenching

Bacterial Quorum Sensing is a cell-to-cell communication process, in which, bacteria, performing cooperative behaviour, produce and detect extracellular signalling chemicals, to monitor

Continue reading

January 21, 2021 CD derivatives / Other industrial use

Cinchonidine-functionalized β-cyclodextrin in catalysis

A short communication from the groups of Univ. Artois, Università degli Studi di Palermo and Charles University, Prague showed that

Continue reading

January 19, 2021 CD derivatives

Nature Protocols: Facile synthesis of per(6-O-tert-butyldimethylsilyl)-α-, β-, and γ-cyclodextrin

Per(6-O–tert-butyldimethylsilyl)-α-, β- and γ-cyclodextrin derivatives are well-known as synthetic intermediates that enable the selective mono-, partial, or perfunctionalization of the

Continue reading

January 14, 2021 CD derivatives / Drug delivery / Pharma applications

CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials

The research group of CNR-ISMN Institute of Nanostructured Materials has developed various CDE-based nanoparticles, nanoassemblies for biomedical applications. Nanoassemblies based

Continue reading

January 11, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs

Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development

Continue reading

January 8, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Announces Positive Efficacy Data in Patients with Niemann-Pick Disease Type C

Home-based intravenous infusions of Trappsol® Cyclo™ for up to one year show improvement in disease features or disease stabilization Cyclo

Continue reading

January 5, 2021 CD as API / CD derivatives / Drug delivery / Pharma applications

Special Issue “Pharmaceutical and Biomedical Applications of Cyclodextrins and Derivatives”

This Special Issue in Pharmaceutics will collect the latest innovative researches in the field of pharmaceutical and biomedical applications of

Continue reading

December 28, 2020 CD derivatives / Drug delivery / Other industrial use / Pharma applications

“Perspectives of Cyclodextrins” special issue

The special issue on “Perspectives of Cyclodextrins” has been published. Guest Editor(s): Susana Santos Braga. https://www.mdpi.com/journal/biomolecules/special_issues/cyclodextrins All articles can be

Continue reading

December 8, 2020 CD derivatives / Environmental

Chapter 8: Water-Insoluble Cyclodextrin-Epichlorohydrin Polymers

The purpose of this chapter is to summarize the research conducted over the past 30 years by the research group

Continue reading

November 30, 2020 CD derivatives / Environmental / Other industrial use

β-cyclodextrin polymer microsphere as a potential filtration reducer in water-based drilling fluids for high temperature application

As the search for energy increases, the drilling depth has increased dramatically due to the progress of drilling technologies over

Continue reading

Posts navigation

«Previous Posts 1 2 3 4 5 … 14 Next Posts»

Recent Posts

  • Registration opened for virtual abridged meeting prior to International Cyclodextrin Symposium
  • Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
  • Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
  • Cyclodextrins in Antiviral Therapeutics and Vaccines
  • FDA granted accelerated approval to umbralisib / HPBCD tablet

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD nanomedicine Nanoparticles nanotechnology Niemann Pick Disease Polymer remdesivir SBECD Special issue Synthesis Trappsol

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (9)
  • Analysis (14)
  • CD as API (106)
  • CD derivatives (140)
  • Cosmetics and toilettry (10)
  • Drug delivery (210)
  • E-ducation (41)
  • Environmental (44)
  • Events (102)
  • Food (60)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (103)
  • Other industrial use (36)
  • Pharma applications (373)
  • Supramolecular systems (7)
  • Uncategorized (23)

Top Posts

  • Registration opened for virtual abridged meeting prior to International Cyclodextrin Symposium
  • Visible Light-Activatable Cyclodextrin-Conjugates for the Efficient Delivery of Nitric Oxide with Fluorescent Reporter and their Inclusion Complexes with Betaxolol
  • Cyclodextrins in Antiviral Therapeutics and Vaccines
  • Evading Thermodynamic Constraints of Cyclodextrin-Drug Formulations
  • FDA granted accelerated approval to umbralisib / HPBCD tablet
  • The monograph of SBECD is official in the European Pharmacopeia
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • How air fresheners work?
  • Host-guest chemistry for the treatment of leishmania
  • Reviews on cyclodextrin-metal-organic frameworks (CD-MOFs) in food applications

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 295 other subscribers